Designing and screening of fluoroquinolone substitutes using combined in silico approaches: biological metabolism–bioconcentration bilateral selection and their mechanism analyses

The study was aimed to design FQ substitutes, improve the bio-metabolism and bio-concentration ability of FQs drugs from the perspective of source control, and provide theoretical support for alleviating the potential environmental risks of FQs.